The Delaware Supreme Court has dramatically reduced the legal fees awarded to attorneys in a shareholder lawsuit against Tesla's board, cutting the sum from $176.1 million to $70.9 million. The ruling, which cited an overvaluation of the settlement, prompted a pointed response from CEO Elon Musk.
A criminal probe into outgoing Fed Chair Jerome Powell, initiated by the Trump administration, has triggered a Senate blockade led by a key Republican. The standoff jeopardizes Kevin Warsh's confirmation and risks delaying the interest rate cuts Trump desires ahead of a tough election.
Bitcoin's recent slump below $74,000 has analysts weighing the risk of a deeper pullback toward $60,000. While Bernstein suggests the downturn may be a late-cycle correction rather than a new crypto winter, the firm points to shifting central bank policies and institutional adoption as keys to the next rally.
A recent adjustment to Airgain's price target by analysts reflects a broader reassessment of the wireless connectivity specialist's prospects, underscoring how evolving narratives, rather than single events, are reshaping investor views on the stock.
Regional banks like Fifth Third are betting on a historic profit surge if Kevin Warsh reshapes the Fed. But Wall Street warns his ambitious plan to slash rates and shrink the balance sheet faces fierce internal and political headwinds, threatening market stability.
A recent analyst price target update for Tesla, devoid of specific figures, has reignited debate over the core drivers of the stock's story. The focus is shifting from pure growth metrics to the underlying expectations and perceived risks surrounding its business model and long-term strategy.
The head of Médecins Sans Frontières warns that Israel's decision to terminate the group's operations in Gaza and the West Bank will deepen the humanitarian crisis, calling it a pretext to restrict vital aid.
If confirmed, incoming Fed Chair Kevin Warsh will inherit a booming yet bifurcated economy. Despite strong GDP growth and a surging stock market, stagnant hiring and sinking consumer confidence present a policy puzzle where interest rate cuts may offer no easy fix.
A Foxboro woman's two-year struggle with a defective high-end oven underscores the enduring power of state consumer protection laws, even after a manufacturer's warranty expires.
Major financial institutions Barclays and Morgan Stanley maintain projections for two interest rate cuts in 2024, despite President Trump's nomination of inflation hawk Kevin Warsh to chair the Federal Reserve. Analysts suggest policy continuity in the near term, though Senate confirmation faces political hurdles.
As Kevin Warsh emerges as a frontrunner for Federal Reserve Chair, former colleagues paint a picture of a consensus-seeking listener. But with the Fed facing internal divisions and external pressure, questions remain: Is his collaborative style the steady hand needed, or a potential liability in times of crisis?
Goldman Sachs raises Sweetgreen's price target to $5.60, citing policy tailwinds for consumer spending, even as it maintains a Sell rating. The salad chain's expansion and strong revenue growth continue to draw investor attention.
Stephens lowers price target on Cal-Maine Foods (CALM) citing near-term oversupply pressures, but the egg producer's long-term strategy remains focused on expanding its cage-free capacity through acquisition.
Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.
Edwards Lifesciences (NYSE: EW) has terminated its planned takeover of JenaValve, opting instead to reinvest capital into its internal transcatheter aortic (TAVR) and mitral valve development programs. The strategic pivot underscores a renewed focus on organic growth in its core structural heart business.
As speculation mounts over the next Federal Reserve leadership, top economists point to Kevin Warsh's crisis-era experience as a strength, but warn his legacy will hinge on a single, monumental challenge: shielding interest-rate policy from political influence.
Despite a 14% share price decline over the past quarter, Associated British Foods (LON:ABF) demonstrates robust underlying financial health, driven by strong earnings growth and efficient capital reinvestment, suggesting potential for a market correction.
A revised analyst price target for Grupo Financiero Banorte (BMV:GFNORTE O) is refocusing investor attention on the Mexican banking giant, highlighting how evolving assessments of risk and growth potential can rapidly reshape a stock's narrative.
Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
